Tocilizumab is a recombinant humanized anti-human IgG1 monoclonal antibody that has been proposed to be of value in the management of severe COVID-19.
CEBMDrug vignettes: Tocilizumab - proposed to be of value in the management of severe #COVID19, explored by Robin E Ferner and Jeffrey K Aronson, on behalf of the Oxford COVID-19 Evidence Service Team: cebm.net/covid-19/tocil…
Carl Heneghan, Tom Jefferson Verdict: The current community transmission of COVID is low and not at epidemic levels. The rates
CEBMWhat does RCGP surveillance tell us about #COVID19 in the community? Are the distancing measures having an effect?
Prof @carlheneghan and Tutor, Tom Jefferson explain: cebm.net/covid-19/what-…
Richard Darby and Tom Darby On behalf of the Oxford COVID-19 Evidence Service Team University of Oxford Correspondence to: [email protected]
CEBMAccording to @LSHtweets, 88% of office workers believe that they could work at least two days a week at home without impacting on their work and mental wellbeing, so what is the post-pandemic future for city centre office space? cebm.net/covid-19/the-p…
Jason Oke, Carl Heneghan NHS England releases data at 2 pm each day and reports daily count up to the
CEBMThe #CEBM is your trusted, evidence-based resource, providing daily updates on #COVID19 death data in England, including weekly comparisons, by region and age.
73% of Hospital Trusts in England have reported no deaths in the last 48 hours: cebm.net/covid-19/covid…
Out of sight, the elderly have remained out of mind during this crisis
CEBMDying of neglect: the other Covid care home scandal
How many #COVID19 related deaths have been as a direct result of the disease itself and how many are victims of the fear and neglect that it has engendered?
Carl Heneghan and Tom Jefferson, discuss